Renal Cell Carcinoma Clinical Trials

A listing of Renal Cell Carcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Renal Cell Carcinoma, Mantle-Cell Lymphoma, Diffuse, Large B-Cell, Lymphoma or Follicular Lymphoma, Grade 3

Birmingham Alabama 35294

A Phase 1/1b clinical study for patients with Advanced Cancer

Birmingham Alabama

Patients are needed to participate in a clinical research study of TRC105 and Axitinib to evaluate Renal Cell Carcinoma

Arizona

Arizona Oncology Associates, PC - HOPE
Tucson Arizona

A Phase 2 Randomized, Double-Blind Study of Dalantercept and Axitinib Compared to Placebo and Axitinib in Patients With Advanced Renal Cell Carcinoma

View More ▼

UPDATED

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Tucson Arizona 85719

A clinical trial to evaluate treatments using RX-0201 and Everolimus for patients with Metastatic Renal Cell Cancer

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Renal Cell Carcinoma

Scottsdale Arizona 85259

A clinical research study of MRX34 for the treatment of Primary Liver Cancer, Solid Tumors or Lymphoma

Scottsdale Arizona 85258

A clinical research study of MRX34 for the treatment of Primary Liver Cancer, Solid Tumors or Lymphoma

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona

Patients are needed to participate in a clinical research study of TRC105 and Axitinib to evaluate Renal Cell Carcinoma

Tucson Arizona 85724

A clinical trial to evaluate treatments using Bevacizumab, MPDL3280A and Sunitinib for patients with Renal Cell Carcinoma, Untreated Advanced Renal Cell Carcinoma

Arkansas

Highlands Oncology Group, PA
Fayetteville Arkansas

A Phase 2 Randomized, Double-Blind Study of Dalantercept and Axitinib Compared to Placebo and Axitinib in Patients With Advanced Renal Cell Carcinoma

California

University of California Irvine Medical Center
Irvine California

A Phase 2 Randomized, Double-Blind Study of Dalantercept and Axitinib Compared to Placebo and Axitinib in Patients With Advanced Renal Cell Carcinoma

University of California, Los Angeles (UCLA) - Institute of Urologic Oncology
Los Angeles California

A Phase 2 Randomized, Double-Blind Study of Dalantercept and Axitinib Compared to Placebo and Axitinib in Patients With Advanced Renal Cell Carcinoma

Mirati Research Site
San Diego California 92093

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Stanford Hospital and Clinics
Stanford California

A Phase 2 Randomized, Double-Blind Study of Dalantercept and Axitinib Compared to Placebo and Axitinib in Patients With Advanced Renal Cell Carcinoma

View More ▼

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using RX-0201 and Everolimus for patients with Metastatic Renal Cell Cancer

UPDATED

La Jolla California 92093

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

La Jolla California 92037

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Los Angeles California

A Phase 1/Phase 2 clinical study for patients with Cancer, Solid Tumor

UPDATED

Orange California 92868

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Panorama City California 91402

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Sacramento California

A Phase 1/Phase 2 clinical study for patients with Cancer, Solid Tumor

UPDATED

San Diego California

A Phase 1/Phase 2 clinical study for patients with Cancer, Solid Tumor

UPDATED

San Francisco California 94143

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Santa Monica California 90403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Duarte California 91010-3000

A clinical trial seeking patients for a research study for the treatment of Renal Cell Carcinoma, Mantle-Cell Lymphoma, Diffuse, Large B-Cell, Lymphoma or Follicular Lymphoma, Grade 3

Duarte California

Patients are needed to participate in a clinical research study of TRC105 and Axitinib to evaluate Renal Cell Carcinoma

Fullerton California 92835

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Renal Cell Carcinoma

Fullerton California

Patients are needed to participate in a clinical research study of TRC105 and Axitinib to evaluate Renal Cell Carcinoma

Loma Linda California 92354

A clinical research study of PEG-BCT-100 for the treatment of Hepatocellular Carcinoma, Renal Cell Carcinoma, Melanoma or Prostate Adenocarcinoma

Los Angeles California 90048

A clinical trial seeking patients for a research study for the treatment of Renal Cell Carcinoma, Mantle-Cell Lymphoma, Diffuse, Large B-Cell, Lymphoma or Follicular Lymphoma, Grade 3

Los Angeles California 90024

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Los Angeles California 90095

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles California 90095

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Renal Cell Carcinoma

Los Angeles California

Patients are needed to participate in a clinical research study of TRC105 and Axitinib to evaluate Renal Cell Carcinoma

Orange California 92868

A clinical study for patients with Kidney Neoplasms

Orange California 92868

A clinical trial to evaluate treatments using Bevacizumab, MPDL3280A and Sunitinib for patients with Renal Cell Carcinoma, Untreated Advanced Renal Cell Carcinoma

Sacramento California

Patients are needed to participate in a clinical research study of TRC105 and Axitinib to evaluate Renal Cell Carcinoma

San Diego California 92123

A clinical research study of Guided Therapy

San Diego California 92093

A Phase 1/1b clinical study for patients with Advanced Cancer

San Francisco California

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

San Francisco California 94143

Patients are needed to participate in a clinical research study of CB-839 for the treatment of Solid Tumors

Santa Maria California 93454

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Renal Cell Carcinoma

Santa Monica California

Patients are needed to participate in a clinical research study evaluating Pembrolizumab, INCB039110 and INCB050465, Advanced Solid Tumors

Stanford California 94305

Patients are needed to participate in a clinical research study of CB-839 for the treatment of Solid Tumors

Colorado

Rocky Mountain Cancer Centers
Aurora Colorado

A Phase 2 Randomized, Double-Blind Study of Dalantercept and Axitinib Compared to Placebo and Axitinib in Patients With Advanced Renal Cell Carcinoma